Plain-English translation of NCT07518069 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand why some people develop Menière's disease — a condition causing dizzy spells, hearing loss, and ear fullness — by studying genetic differences in people's blood. This study will compare genetic and chemical markers in people with Menière's disease, people with a related condition called vestibular migraine, and people without balance problems. The goal is to identify genetic patterns that might explain why these inner ear disorders develop.
Menière's disease and related balance disorders run in some families, suggesting genetics play a role, but scientists haven't yet figured out which genes are involved. This study aims to fill that gap by looking at genes involved in maintaining the delicate balance of fluids and minerals in the inner ear — a key factor in how these disorders develop.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a single blood sample drawn, which researchers will then analyze for genetic and chemical markers. You may also be asked basic health questions. The study is comparing three groups — people with Menière's disease, people with vestibular migraine, and people without balance problems — to identify patterns that distinguish them.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy
Sponsor
IRCCS San Raffaele
Enrollment target
~250 participants
Started
April 2025
Primary completion
April 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Roberto Carlo Teggi, MD
IRCCS San Raffaele
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.